First reported by Pharmacy Times
<![CDATA[Study Links Several Progestogen Contraceptives to Rare Meningioma Risk, Reinforcing Individualized Patient Counseling]]>
Meningioma Risk Warning With Progestogen Contraceptives
The EMA has alerted healthcare professionals to a small increased risk for meningioma with the progestogen-based contraceptives desogestrel and etonogestrel. Medscape News Europe
Read the full article8h agoen
You might also wanna read
<![CDATA[Study Links Several Progestogen Contraceptives to Rare Meningioma Risk, Reinforcing Individualized Patient Counseling]]>
Pharmacy Times·2d ago
La EMA informa de un ligero aumento del riesgo de meningioma asociado a anticonceptivos con desogestrel o etonogestrel
Infobae·6h ago

Contraccettivi, allarme meningioma dell'Ema: rischio aumentato con uso prolungato. Ecco di quali
Un uso prolungato dei contraccettivi a base di desogestrel ed etonogestrel è associato a un lieve aumento del rischio di meningioma, un tumo
ilmessaggero.it

Cáncer de endometrio: cuáles son los síntomas y qué factores elevan el riesgo
Especialistas en salud reproductiva recomiendan consultar ante irregularidades o molestias inusuales en el ciclo menstrual, y advierten sobr
Infobae·10h ago
EMA's PRAC finds inconsistent evidence linking valproate to neurodevelopmental disorders in children of treated men
PRAC concludes evaluation of new data regarding potential risk of neurodevelopmental disorders in children born to men treated with valproat
Mayo Clinic Study Maps Meningioma Tumor Environment, Revealing Drivers of Disease Behavior
Mayo Clinic researchers are advancing brain tumor care through molecular profiling, improved diagnostics for younger patients, new drug deli

Comments
Sign in to join the conversation.
No comments yet. Be the first.